Interleukin-12 Antagonist [EPC]

Interleukin-12 Antagonist [EPC] was reported 103830 times

Drugs of the Interleukin-12 Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 414 0.6198
1 SWOLLEN JOINT COUNT INCREASED 1922 0.6021
2 RHEUMATIC FEVER 2543 0.5699
3 LUPUS VULGARIS 682 0.5413
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 1066 0.5322
5 C-REACTIVE PROTEIN 492 0.5302
6 RHEUMATOID FACTOR POSITIVE 2982 0.5157
7 SWOLLEN JOINT COUNT 128 0.5120
8 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3625 0.5054
9 GRIP STRENGTH 113 0.4934
10 RED BLOOD CELL SEDIMENTATION RATE 127 0.4552
11 FACET JOINT SYNDROME 1431 0.4391
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 883 0.4260
13 DUODENAL ULCER PERFORATION 3156 0.4240
14 X-RAY ABNORMAL 735 0.4106
15 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 216 0.3850
16 RETINITIS 661 0.3823
17 DISLOCATION OF VERTEBRA 838 0.3672
18 ILEOCAECAL RESECTION 123 0.3576
19 NEUROLOGIC NEGLECT SYNDROME 178 0.3201
20 HELICOBACTER INFECTION 3256 0.3164
21 PEMPHIGUS 3944 0.3152
22 HAND DEFORMITY 4061 0.3093
23 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 32 0.3048
24 C-REACTIVE PROTEIN ABNORMAL 1788 0.2785
25 MUSCLE INJURY 2219 0.2675
26 PERIPHERAL VENOUS DISEASE 1080 0.2642
27 SERONEGATIVE ARTHRITIS 298 0.2600
28 SYNOVITIS 4640 0.2571
29 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1654 0.2545
30 FOLLICULITIS 2611 0.2489
31 PERICARDITIS 3881 0.2308
32 CONTRAINDICATION TO VACCINATION 42 0.2199
33 BONE EROSION 777 0.2195
34 ILEECTOMY 72 0.2136
35 CAROTID ARTERY THROMBOSIS 181 0.2134
36 HYPOCHOLESTEROLAEMIA 65 0.1841
37 GLOSSODYNIA 4074 0.1818
38 PROCTOCOLECTOMY 55 0.1803
39 GRANULOMA SKIN 143 0.1742
40 ENTHESOPATHY 272 0.1740
41 DRUG TOLERANCE DECREASED 472 0.1679
42 PORPHYRIA ACUTE 236 0.1645
43 BREAST CANCER STAGE III 1042 0.1608
44 LIP DRY 1461 0.1607
45 OVERLAP SYNDROME 106 0.1514
46 WOUND 4231 0.1512
47 HYPERCHOLESTEROLAEMIA 1353 0.1400
48 JOINT RANGE OF MOTION DECREASED 1828 0.1361
49 ADJUSTMENT DISORDER 176 0.1356
50 TERMINAL ILEITIS 83 0.1352
51 WOUND INFECTION 1478 0.1348
52 GRIP STRENGTH DECREASED 1176 0.1335
53 SYRINGE ISSUE 2297 0.1311
54 INTESTINAL ANASTOMOSIS 84 0.1304
55 ONYCHOMADESIS 525 0.1250
56 FAECAL CALPROTECTIN ABNORMAL 51 0.1229
57 PUSTULAR PSORIASIS 421 0.1224
58 SYSTEMIC LUPUS ERYTHEMATOSUS 4292 0.1208
59 ANASTOMOTIC STENOSIS 45 0.1206
60 IRRITABLE BOWEL SYNDROME 2550 0.1188
61 DEATH NEONATAL 155 0.1113
62 BURSITIS 1347 0.1109
63 AUTOIMMUNE DISORDER 1079 0.1106
64 LIVE BIRTH 922 0.1101
65 PSORIATIC ARTHROPATHY 4423 0.1089
66 BLOOD PARATHYROID HORMONE DECREASED 158 0.1065
67 ERYTHRODERMIC PSORIASIS 84 0.1019
68 ARTHRITIS ENTEROPATHIC 33 0.1009
69 FIBROMYALGIA 2434 0.1000
70 BLEPHAROSPASM 615 0.0976
71 TENOSYNOVITIS 267 0.0967
72 CONTRAINDICATED PRODUCT ADMINISTERED 2912 0.0961
73 INTESTINAL RESECTION 513 0.0952
74 LOWER RESPIRATORY TRACT INFECTION 4259 0.0936
75 JOINT ANKYLOSIS 53 0.0933
76 ONYCHOMYCOSIS 403 0.0917
77 ILEAL STENOSIS 160 0.0900
78 SMALL INTESTINAL RESECTION 104 0.0892
79 EXOSTOSIS 804 0.0880
80 ALANINE AMINOTRANSFERASE ABNORMAL 185 0.0876
81 LUPUS-LIKE SYNDROME 783 0.0863
82 TYPE 2 DIABETES MELLITUS 2906 0.0862
83 INFECTED FISTULA 46 0.0858
84 LIVER INJURY 2101 0.0855
85 ILEOSTOMY 210 0.0823
86 IMPAIRED HEALING 2667 0.0811
87 DEVICE DEFECTIVE 1399 0.0806
88 LATENT TUBERCULOSIS 168 0.0802
89 THERAPEUTIC PRODUCT EFFECT DECREASED 3552 0.0792
90 SCIATICA 1263 0.0792
91 INFUSION RELATED REACTION 5236 0.0789
92 FINGER DEFORMITY 373 0.0769
93 RED BLOOD CELL SEDIMENTATION RATE INCREASED 847 0.0765
94 POSTOPERATIVE ABSCESS 51 0.0765
95 OBESITY 1178 0.0739
96 NEEDLE ISSUE 2138 0.0734
97 ARTHROPATHY 4078 0.0733
98 ANAL ABSCESS 395 0.0732
99 ANAL STENOSIS 39 0.0732
100 FAECAL CALPROTECTIN INCREASED 230 0.0726
101 HIP ARTHROPLASTY 1088 0.0710
102 NAIL DISORDER 619 0.0707
103 PANNICULITIS 171 0.0706
104 WALKING AID USER 461 0.0698
105 RECTAL ABSCESS 116 0.0691
106 JOINT DISLOCATION 727 0.0687
107 PRODUCT LEAKAGE 385 0.0685
108 PERSONALITY DISORDER 178 0.0679
109 HEPATIC ENZYME INCREASED 4532 0.0664
110 COLECTOMY TOTAL 37 0.0662
111 ILEAL ULCER 66 0.0652
112 GUTTATE PSORIASIS 53 0.0646
113 FOOT DEFORMITY 709 0.0639
114 PULMONARY FIBROSIS 1212 0.0632
115 MATERNAL EXPOSURE TIMING UNSPECIFIED 237 0.0630
116 SPONDYLITIS 229 0.0629
117 LOWER LIMB FRACTURE 1189 0.0618
118 COLECTOMY 347 0.0614
119 LARYNGITIS 662 0.0612
120 RHEUMATOID NODULE 165 0.0598
121 LARGE INTESTINAL STENOSIS 119 0.0595
122 DEVICE DEPLOYMENT ISSUE 751 0.0587
123 PRESCRIBED OVERDOSE 1108 0.0572
124 BLOOD CHOLESTEROL INCREASED 2655 0.0569
125 DISCOMFORT 3460 0.0566
126 INTESTINAL STENOSIS 239 0.0566
127 CUTANEOUS T-CELL LYMPHOMA 70 0.0556
128 ABSCESS INTESTINAL 119 0.0552
129 DRUG SPECIFIC ANTIBODY 75 0.0547
130 SACROILIITIS 103 0.0545
131 PRODUCT LABEL CONFUSION 317 0.0543
132 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 127 0.0535
133 BLISTER 2919 0.0519
134 BREAST CANCER STAGE II 426 0.0512
135 INTESTINAL OPERATION 81 0.0511
136 PYODERMA GANGRENOSUM 183 0.0508
137 PSORIASIS 6636 0.0508
138 KNEE ARTHROPLASTY 1063 0.0505
139 ANAL FISTULA 269 0.0504
140 HEPATIC CIRRHOSIS 942 0.0501
141 RASH VESICULAR 242 0.0500
142 DACTYLITIS 49 0.0499
143 GAIT INABILITY 1660 0.0496
144 GROIN ABSCESS 58 0.0492
145 INFUSION SITE REACTION 147 0.0492
146 STOMA CREATION 34 0.0490
147 ENTEROCUTANEOUS FISTULA 43 0.0488
148 EYE INJURY 148 0.0487
149 TREATMENT FAILURE 3937 0.0475
150 STENOSIS 89 0.0473
151 SUSPECTED OFF LABEL USE 214 0.0473
152 SMALL INTESTINAL STENOSIS 50 0.0469
153 INTESTINAL FISTULA 66 0.0468
154 BACK INJURY 507 0.0466
155 OSTEOARTHRITIS 1967 0.0463
156 RHEUMATOID LUNG 44 0.0461
157 ULCER HAEMORRHAGE 312 0.0461
158 DRUG INTOLERANCE 4327 0.0447
159 PERFORATION 36 0.0447
160 STOMATITIS 2693 0.0444
161 NIGHT SWEATS 1408 0.0437
162 SWELLING 4070 0.0434
163 RHEUMATOID ARTHRITIS 4920 0.0433
164 CHOLANGITIS SCLEROSING 89 0.0433
165 C-REACTIVE PROTEIN INCREASED 1576 0.0433
166 PRODUCT OUTER PACKAGING ISSUE 39 0.0431
167 LOSS OF THERAPEUTIC RESPONSE 135 0.0423
168 PRESCRIBED UNDERDOSE 833 0.0417
169 LIVER FUNCTION TEST INCREASED 889 0.0414
170 INFLAMMATION 2107 0.0408
171 GASTROENTERITIS NOROVIRUS 54 0.0406
172 MOBILITY DECREASED 2917 0.0406
173 JOINT SWELLING 4797 0.0397
174 POUCHITIS 34 0.0395
175 TUBERCULIN TEST POSITIVE 100 0.0394
176 BONE CYST 37 0.0394
177 INJURY 2753 0.0391
178 ABDOMINAL ABSCESS 172 0.0389
179 GASTROINTESTINAL WALL THICKENING 58 0.0387
180 DRUG DELIVERY SYSTEM MALFUNCTION 198 0.0387
181 FISTULA 429 0.0381
182 FISTULA DISCHARGE 48 0.0380
183 COELIAC DISEASE 370 0.0377
184 CONGENITAL ANOMALY 290 0.0374
185 MUSCULOSKELETAL STIFFNESS 3254 0.0371
186 EXPOSURE DURING PREGNANCY 2302 0.0370
187 BASAL CELL CARCINOMA 574 0.0368
188 DRUG LEVEL DECREASED 372 0.0365
189 INJECTION RELATED REACTION 60 0.0363
190 WHEEZING 2139 0.0360
191 THERAPY NON-RESPONDER 1583 0.0352
192 GENERAL PHYSICAL HEALTH DETERIORATION 4047 0.0349
193 MALIGNANT MELANOMA IN SITU 43 0.0347
194 SPINAL FUSION SURGERY 141 0.0347
195 COLOSTOMY 68 0.0346
196 COLITIS ULCERATIVE 1545 0.0345
197 ROAD TRAFFIC ACCIDENT 1441 0.0344
198 PROSTATE INFECTION 33 0.0343
199 INFECTED CYST 41 0.0342
200 ADENOCARCINOMA OF COLON 64 0.0341
201 ILL-DEFINED DISORDER 2060 0.0339
202 LIQUID PRODUCT PHYSICAL ISSUE 247 0.0338
203 DERMATITIS PSORIASIFORM 69 0.0337
204 GASTROINTESTINAL STOMA COMPLICATION 53 0.0337
205 ABSCESS 536 0.0336
206 MATERNAL EXPOSURE DURING PREGNANCY 2984 0.0334
207 INTESTINAL ULCER 52 0.0327
208 SKIN NECROSIS 169 0.0325
209 PERTUSSIS 34 0.0325
210 LIVER DISORDER 1421 0.0320
211 TONGUE DISORDER 230 0.0318
212 SQUAMOUS CELL CARCINOMA 299 0.0317
213 GANGRENE 191 0.0317
214 JOINT STIFFNESS 831 0.0316
215 OEDEMA 1711 0.0315
216 FREQUENT BOWEL MOVEMENTS 842 0.0311
217 VEIN RUPTURE 52 0.0310
218 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 71 0.0308
219 DRUG TOLERANCE 156 0.0308
220 GASTROINTESTINAL BACTERIAL INFECTION 35 0.0307
221 DRUG LEVEL BELOW THERAPEUTIC 168 0.0304
222 LUNG DISORDER 1451 0.0296
223 SLEEP DISORDER 2071 0.0293
224 PRODUCT USE ISSUE 5476 0.0291
225 EAR INFECTION 772 0.0290
226 SINUSITIS 2948 0.0287
227 GENERAL SYMPTOM 215 0.0287
228 GASTROINTESTINAL DISORDER 2531 0.0282
229 POSTOPERATIVE WOUND INFECTION 190 0.0281
230 CERVICAL DYSPLASIA 61 0.0279
231 INTESTINAL DILATATION 37 0.0277
232 PRODUCT LABEL ISSUE 187 0.0275
233 DRUG-INDUCED LIVER INJURY 861 0.0274
234 SENSORY LOSS 220 0.0273
235 JOINT DESTRUCTION 42 0.0270
236 FEMALE GENITAL TRACT FISTULA 46 0.0269
237 INTENTIONAL PRODUCT USE ISSUE 2359 0.0269
238 INFLAMMATORY BOWEL DISEASE 263 0.0269
239 MYOSITIS 239 0.0266
240 MUCOUS STOOLS 131 0.0264
241 TOOTH ABSCESS 269 0.0264
242 DELIRIUM 909 0.0262
243 ABDOMINAL DISCOMFORT 4391 0.0261
244 NORMAL NEWBORN 142 0.0261
245 MASTITIS 49 0.0261
246 TASTE DISORDER 529 0.0260
247 ADVERSE REACTION 344 0.0259
248 MUSCULOSKELETAL PAIN 1354 0.0258
249 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 443 0.0258
250 GASTROINTESTINAL INFLAMMATION 202 0.0258
251 PREGNANCY 515 0.0257
252 SUBCUTANEOUS ABSCESS 123 0.0257
253 PRODUCT DOSE OMISSION 1671 0.0256
254 HYPERSENSITIVITY 4739 0.0255
255 DISABILITY 504 0.0255
256 TONSILLITIS 133 0.0255
257 DRUG ERUPTION 450 0.0254
258 DERMATITIS EXFOLIATIVE GENERALISED 87 0.0250
259 INFECTION 3602 0.0249
260 SKIN PLAQUE 207 0.0245
261 PRODUCT PACKAGING ISSUE 233 0.0245
262 LARGE INTESTINAL ULCER 66 0.0243
263 PROCTITIS 68 0.0243
264 THERAPEUTIC RESPONSE DECREASED 1470 0.0242
265 CLOSTRIDIUM DIFFICILE INFECTION 521 0.0238
266 EPILEPSY 720 0.0235
267 ALOPECIA 4615 0.0235
268 MUSCLE SPASTICITY 287 0.0233
269 HEMIPLEGIA 194 0.0233
270 ARTERIAL OCCLUSIVE DISEASE 183 0.0232
271 INCORRECT PRODUCT STORAGE 304 0.0231
272 SINUS CONGESTION 310 0.0229
273 DEVICE ISSUE 2021 0.0225
274 DRUG SPECIFIC ANTIBODY PRESENT 146 0.0224
275 PAPILLOMA VIRAL INFECTION 37 0.0224
276 CHOLANGIOCARCINOMA 33 0.0221
277 SALMONELLOSIS 37 0.0219
278 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1558 0.0219
279 HEPATIC FIBROSIS 75 0.0218
280 ARTHRITIS 1715 0.0218
281 GASTROINTESTINAL INFECTION 195 0.0217
282 POST PROCEDURAL INFECTION 176 0.0216
283 IGA NEPHROPATHY 35 0.0211
284 ENTERITIS 135 0.0211
285 SKIN HAEMORRHAGE 310 0.0209
286 CONTUSION 1999 0.0207
287 INVASIVE DUCTAL BREAST CARCINOMA 56 0.0206
288 GRANULOMA 71 0.0205
289 ERYSIPELAS 102 0.0203
290 DRY MOUTH 1646 0.0203
291 NASOPHARYNGITIS 3732 0.0202
292 OSTEOPOROSIS 827 0.0201
293 KIDNEY INFECTION 393 0.0200
294 AFFECT LABILITY 190 0.0197
295 SMALL INTESTINAL OBSTRUCTION 242 0.0196
296 PRODUCT CONTAINER SEAL ISSUE 34 0.0195
297 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 928 0.0193
298 ANORECTAL DISORDER 38 0.0191
299 TENDONITIS 295 0.0190
300 VITAMIN B12 DEFICIENCY 77 0.0190
301 SUBILEUS 39 0.0187
302 PERIPHERAL SWELLING 2888 0.0187
303 CYTOMEGALOVIRUS COLITIS 43 0.0187
304 MOTOR DYSFUNCTION 190 0.0186
305 ADVERSE EVENT 1717 0.0186
306 ABSCESS LIMB 79 0.0185
307 MALIGNANT MELANOMA 248 0.0185
308 DEFAECATION URGENCY 129 0.0184
309 ABDOMINAL INFECTION 47 0.0184
310 WEIGHT FLUCTUATION 192 0.0183
311 VARICELLA ZOSTER VIRUS INFECTION 38 0.0183
312 HYPOAESTHESIA 2712 0.0181
313 HIDRADENITIS 164 0.0180
314 JOINT ARTHROPLASTY 32 0.0178
315 SELF-MEDICATION 73 0.0177
316 CELLULITIS 888 0.0176
317 CONDITION AGGRAVATED 5349 0.0176
318 ANTINUCLEAR ANTIBODY POSITIVE 57 0.0175
319 ULCER 279 0.0175
320 SKIN INJURY 58 0.0175
321 POLYARTHRITIS 92 0.0174
322 FEAR OF INJECTION 124 0.0174
323 TUBERCULOSIS 223 0.0173
324 UPPER RESPIRATORY TRACT INFECTION 800 0.0173
325 MIGRAINE 1644 0.0172
326 SKIN INFECTION 192 0.0171
327 OSTEOLYSIS 35 0.0171
328 RHEUMATIC DISORDER 33 0.0171
329 OBSTRUCTION 68 0.0170
330 GASTROINTESTINAL OBSTRUCTION 41 0.0170
331 DYSPEPSIA 1669 0.0169
332 INTESTINAL OBSTRUCTION 635 0.0168
333 CONFUSIONAL STATE 2718 0.0168
334 RENAL NEOPLASM 35 0.0165
335 DYSCHEZIA 50 0.0164
336 EAR PAIN 318 0.0163
337 HEPATITIS 417 0.0163
338 ERYTHEMA NODOSUM 57 0.0162
339 ANAL FISSURE 87 0.0162
340 HYPERTENSION 3417 0.0161
341 DIARRHOEA HAEMORRHAGIC 150 0.0160
342 HEPATIC STEATOSIS 297 0.0159
343 GASTRIC INFECTION 61 0.0159
344 PRODUCT STORAGE ERROR 1387 0.0158
345 EXPOSURE VIA BREAST MILK 63 0.0158
346 DEMYELINATION 64 0.0156
347 UNDERDOSE 1129 0.0155
348 SUSPECTED COVID-19 51 0.0154
349 VITILIGO 36 0.0153
350 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2751 0.0152
351 BACK DISORDER 247 0.0152
352 VARICELLA 36 0.0151
353 LYME DISEASE 50 0.0150
354 SKIN PAPILLOMA 60 0.0149
355 INFLAMMATORY MARKER INCREASED 74 0.0149
356 OFF LABEL USE 12938 0.0148
357 ADENOCARCINOMA 33 0.0147
358 RECTAL CANCER 45 0.0146
359 ACCIDENTAL EXPOSURE TO PRODUCT 1505 0.0146
360 AMNESIA 949 0.0146
361 FACIAL PARALYSIS 124 0.0145
362 DRUG HYPERSENSITIVITY 2777 0.0143
363 ARTHRALGIA 5922 0.0142
364 WEIGHT INCREASED 3179 0.0142
365 APPENDICITIS 132 0.0141
366 HAEMATOCHEZIA 780 0.0141
367 RESPIRATORY DISORDER 422 0.0141
368 RESPIRATORY TRACT CONGESTION 223 0.0140
369 DENGUE FEVER 32 0.0139
370 PUSTULE 33 0.0139
371 SINUS DISORDER 273 0.0138
372 LUNG ADENOCARCINOMA 41 0.0136
373 PNEUMONIA 4399 0.0136
374 COORDINATION ABNORMAL 189 0.0135
375 RESPIRATORY TRACT INFECTION 352 0.0135
376 HYPERCALCAEMIA 166 0.0134
377 CUSHINGOID 43 0.0134
378 GUILLAIN-BARRE SYNDROME 64 0.0132
379 RASH 5724 0.0131
380 SURGERY 762 0.0130
381 DERMATITIS EXFOLIATIVE 65 0.0130
382 CHOLECYSTITIS INFECTIVE 36 0.0130
383 MUSCULAR WEAKNESS 1448 0.0127
384 RECTAL HAEMORRHAGE 544 0.0126
385 APPENDICECTOMY 45 0.0126
386 SKIN CANCER 266 0.0123
387 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 208 0.0122
388 CYSTITIS 390 0.0122
389 ASTHMA 1377 0.0122
390 APHTHOUS ULCER 94 0.0121
391 STREPTOCOCCAL INFECTION 67 0.0120
392 COLITIS 456 0.0120
393 DRUG DOSE OMISSION 1984 0.0120
394 VARICES OESOPHAGEAL 36 0.0119
395 PHARYNGITIS 147 0.0118
396 RASH PUSTULAR 86 0.0118
397 HYPERTRANSAMINASAEMIA 82 0.0118
398 CUTANEOUS VASCULITIS 43 0.0118
399 SQUAMOUS CELL CARCINOMA OF SKIN 71 0.0117
400 IRON DEFICIENCY ANAEMIA 108 0.0117
401 ABDOMINAL PAIN UPPER 2406 0.0117
402 PROCTALGIA 75 0.0117
403 PLANTAR FASCIITIS 39 0.0116
404 HEMIPARESIS 196 0.0116
405 LOCALISED INFECTION 279 0.0115
406 ABDOMINAL PAIN 2676 0.0115
407 INTESTINAL PERFORATION 129 0.0115
408 SKIN ULCER 294 0.0114
409 DRUG INEFFECTIVE 14979 0.0114
410 NECK PAIN 633 0.0113
411 MEDICATION ERROR 626 0.0113
412 CLOSTRIDIAL INFECTION 38 0.0112
413 CHEMOTHERAPY 42 0.0111
414 FUNCTIONAL GASTROINTESTINAL DISORDER 38 0.0110
415 THERAPY CHANGE 108 0.0110
416 MELANOCYTIC NAEVUS 48 0.0109
417 IRON DEFICIENCY 49 0.0109
418 DIVERTICULITIS 301 0.0109
419 EATING DISORDER 231 0.0108
420 WOUND COMPLICATION 37 0.0108
421 MEMORY IMPAIRMENT 1477 0.0107
422 HYSTERECTOMY 93 0.0107
423 SNEEZING 240 0.0107
424 UVEITIS 145 0.0107
425 ARTHRITIS INFECTIVE 49 0.0106
426 PYELONEPHRITIS 91 0.0105
427 FURUNCLE 83 0.0105
428 PAIN 6336 0.0103
429 B-CELL LYMPHOMA 35 0.0103
430 SECRETION DISCHARGE 129 0.0103
431 BRONCHITIS 760 0.0103
432 DECREASED APPETITE 2368 0.0102
433 HERPES VIRUS INFECTION 58 0.0101
434 BILE DUCT STONE 32 0.0100
435 GASTROOESOPHAGEAL REFLUX DISEASE 808 0.0100
436 HEPATIC CYST 34 0.0100
437 DRUG EFFECT DECREASED 539 0.0100
438 GASTROENTERITIS 146 0.0100
439 CHEST PAIN 1847 0.0100
440 DEVICE MALFUNCTION 698 0.0099
441 SKIN DISORDER 330 0.0099
442 MUSCLE SPASMS 1815 0.0099
443 HEPATIC FUNCTION ABNORMAL 367 0.0098
444 OESOPHAGEAL CANDIDIASIS 39 0.0098
445 SARS-COV-2 TEST POSITIVE 129 0.0098
446 ANKYLOSING SPONDYLITIS 128 0.0097
447 LYMPHOMA 150 0.0097
448 RED CELL DISTRIBUTION WIDTH INCREASED 40 0.0096
449 PARAESTHESIA 1511 0.0096
450 TOOTH INFECTION 126 0.0095
451 PRODUCT USE IN UNAPPROVED INDICATION 2369 0.0095
452 INJECTION SITE REACTION 657 0.0095
453 SYMPTOM RECURRENCE 57 0.0095
454 PAIN IN EXTREMITY 2801 0.0095
455 ARTHRITIS BACTERIAL 39 0.0095
456 ARTHROPOD BITE 70 0.0094
457 STAPHYLOCOCCAL INFECTION 309 0.0094
458 CARPAL TUNNEL SYNDROME 131 0.0093
459 PRURITUS 3593 0.0093
460 OEDEMA PERIPHERAL 1139 0.0093
461 PRODUCT TEMPERATURE EXCURSION ISSUE 48 0.0093
462 PHARYNGITIS STREPTOCOCCAL 101 0.0093
463 NONSPECIFIC REACTION 51 0.0093
464 PYREXIA 3202 0.0092
465 ESCHERICHIA INFECTION 76 0.0092
466 NEPHROLITHIASIS 423 0.0092
467 PANCREATITIS 487 0.0092
468 LIVER FUNCTION TEST ABNORMAL 267 0.0092
469 VULVOVAGINAL MYCOTIC INFECTION 36 0.0091
470 HERPES ZOSTER 521 0.0091
471 VASCULAR DEVICE INFECTION 41 0.0090
472 SKIN LESION 247 0.0090
473 HAEMORRHAGIC DIATHESIS 32 0.0090
474 FATIGUE 6993 0.0090
475 HEPATOCELLULAR CARCINOMA 68 0.0089
476 WOUND SECRETION 35 0.0089
477 FAECES SOFT 65 0.0089
478 CHOLELITHIASIS 291 0.0089
479 ANGINA PECTORIS 254 0.0089
480 POLYP 58 0.0088
481 SARCOIDOSIS 42 0.0088
482 DRUG EFFECT INCOMPLETE 319 0.0088
483 RASH PRURITIC 475 0.0088
484 BOWEL MOVEMENT IRREGULARITY 67 0.0087
485 INTENTIONAL DOSE OMISSION 249 0.0087
486 OSTEOMYELITIS 158 0.0087
487 INTRACRANIAL ANEURYSM 35 0.0087
488 COLON CANCER 130 0.0087
489 MALAISE 3811 0.0087
490 PULMONARY TUBERCULOSIS 37 0.0087
491 IMMUNE SYSTEM DISORDER 114 0.0086
492 VIRAL UPPER RESPIRATORY TRACT INFECTION 41 0.0086
493 HEADACHE 5395 0.0086
494 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 610 0.0086
495 INTESTINAL HAEMORRHAGE 48 0.0085
496 PREMATURE LABOUR 48 0.0085
497 SPINAL STENOSIS 35 0.0085
498 CERVIX CARCINOMA 33 0.0084
499 RHINITIS 68 0.0084
500 SHOULDER OPERATION 36 0.0084
501 GASTRIC DISORDER 287 0.0084
502 CHOLECYSTECTOMY 95 0.0083
503 STAPHYLOCOCCAL BACTERAEMIA 36 0.0083
504 INSOMNIA 2199 0.0082
505 EYE INFECTION 92 0.0081
506 THERAPY CESSATION 418 0.0081
507 HEPATITIS B 49 0.0081
508 HERNIA 156 0.0081
509 LUNG INFECTION 125 0.0080
510 INSURANCE ISSUE 123 0.0080
511 ABDOMINAL DISTENSION 839 0.0080
512 GAIT DISTURBANCE 1536 0.0080
513 DIVERTICULUM INTESTINAL 35 0.0080
514 ORAL CANDIDIASIS 105 0.0080
515 MALNUTRITION 89 0.0079
516 IMMUNOSUPPRESSION 70 0.0079
517 CONGESTIVE CARDIOMYOPATHY 33 0.0079
518 POOR QUALITY DRUG ADMINISTERED 51 0.0079
519 ANAL INCONTINENCE 70 0.0078
520 VISUAL IMPAIRMENT 962 0.0078
521 DEPRESSION 1763 0.0077
522 LYMPHADENOPATHY 271 0.0076
523 NEOPLASM 88 0.0076
524 ABDOMINAL TENDERNESS 38 0.0076
525 JOINT INJURY 163 0.0076
526 WHITE BLOOD CELL COUNT INCREASED 292 0.0076
527 BLOOD PRESSURE DIASTOLIC INCREASED 35 0.0076
528 IMMUNODEFICIENCY 113 0.0076
529 DEVICE PHYSICAL PROPERTY ISSUE 58 0.0076
530 LABORATORY TEST ABNORMAL 223 0.0075
531 DIARRHOEA 4840 0.0075
532 VITAMIN D DEFICIENCY 73 0.0075
533 BLOOD PRESSURE SYSTOLIC INCREASED 146 0.0075
534 ABDOMINAL HERNIA 34 0.0074
535 IMPAIRED QUALITY OF LIFE 107 0.0074
536 POOR QUALITY PRODUCT ADMINISTERED 78 0.0074
537 THYROID CANCER 89 0.0074
538 HERPES SIMPLEX 48 0.0074
539 DECREASED IMMUNE RESPONSIVENESS 72 0.0073
540 BLOOD IRON DECREASED 87 0.0073
541 VOMITING 3436 0.0073
542 APHASIA 220 0.0073
543 PRODUCT PACKAGING QUANTITY ISSUE 82 0.0072
544 MENINGITIS 48 0.0072
545 BREAST MASS 48 0.0071
546 DEVICE RELATED INFECTION 110 0.0071
547 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 68 0.0071
548 PLEURISY 42 0.0071
549 FUNGAL INFECTION 235 0.0070
550 HOSPITALISATION 1081 0.0070
551 ORAL HERPES 137 0.0070
552 HEPATIC ENZYME ABNORMAL 35 0.0070
553 KNEE OPERATION 69 0.0070
554 CANDIDA INFECTION 118 0.0070
555 CATARACT 413 0.0069
556 GASTROENTERITIS VIRAL 125 0.0069
557 PULMONARY MASS 103 0.0069
558 PEMPHIGOID 52 0.0069
559 SKIN MASS 46 0.0069
560 CYST 85 0.0068
561 HIP SURGERY 37 0.0068
562 ABNORMAL FAECES 56 0.0068
563 WEIGHT DECREASED 1902 0.0068
564 MASS 95 0.0068
565 TRANSAMINASES INCREASED 151 0.0068
566 RENAL CELL CARCINOMA 33 0.0067
567 ALANINE AMINOTRANSFERASE INCREASED 413 0.0067
568 GASTROINTESTINAL CARCINOMA 61 0.0067
569 INFLUENZA LIKE ILLNESS 551 0.0067
570 FEELING HOT 410 0.0067
571 NEOPLASM MALIGNANT 446 0.0067
572 SPINAL PAIN 78 0.0067
573 ILEUS 82 0.0066
574 TENDON DISORDER 43 0.0066
575 AUTOIMMUNE HEPATITIS 45 0.0065
576 CHOLECYSTITIS 77 0.0065
577 PRODUCT PRESCRIBING ERROR 154 0.0065
578 POST PROCEDURAL COMPLICATION 124 0.0065
579 TENDERNESS 67 0.0064
580 URINARY TRACT INFECTION 1095 0.0064
581 LARGE INTESTINE POLYP 44 0.0063
582 ANKLE FRACTURE 98 0.0063
583 ANAPHYLACTIC REACTION 349 0.0063
584 SKIN EXFOLIATION 531 0.0063
585 VIRAL INFECTION 209 0.0063
586 SKIN LACERATION 68 0.0062
587 FOETAL EXPOSURE DURING PREGNANCY 508 0.0062
588 RHINORRHOEA 402 0.0062
589 OVARIAN CYST 62 0.0062
590 CORONAVIRUS INFECTION 41 0.0062
591 ASPARTATE AMINOTRANSFERASE INCREASED 329 0.0062
592 CHOLECYSTITIS ACUTE 35 0.0062
593 ABORTION SPONTANEOUS 247 0.0062
594 GENERALISED ERYTHEMA 35 0.0061
595 ASTHENIA 2292 0.0061
596 CONCUSSION 47 0.0061
597 COVID-19 1063 0.0061
598 LARGE INTESTINE PERFORATION 42 0.0060
599 INCONTINENCE 64 0.0060
600 HEPATITIS C 73 0.0060
601 SKIN WARM 35 0.0060
602 TREATMENT NONCOMPLIANCE 328 0.0060
603 HYPERKERATOSIS 33 0.0060
604 ADRENAL INSUFFICIENCY 72 0.0059
605 GENERAL PHYSICAL CONDITION ABNORMAL 40 0.0059
606 FLUID RETENTION 300 0.0059
607 QUALITY OF LIFE DECREASED 79 0.0059
608 DYSARTHRIA 221 0.0059
609 UROSEPSIS 54 0.0058
610 MUSCULOSKELETAL DISORDER 111 0.0058
611 ANXIETY 1647 0.0058
612 PRODUCT COMPLAINT 146 0.0058
613 UTERINE CANCER 46 0.0057
614 NAUSEA 4527 0.0057
615 LUNG NEOPLASM MALIGNANT 235 0.0057
616 SEPSIS 635 0.0057
617 VASCULITIS 66 0.0057
618 BRAIN NEOPLASM 52 0.0057
619 DERMATITIS 118 0.0056
620 DIZZINESS 2809 0.0056
621 DYSPNOEA 3160 0.0056
622 HAEMORRHOIDS 108 0.0055
623 SKIN REACTION 78 0.0055
624 TRANSIENT ISCHAEMIC ATTACK 186 0.0055
625 PRODUCT DISTRIBUTION ISSUE 51 0.0055
626 SCAB 62 0.0054
627 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 298 0.0054
628 PAPULE 38 0.0054
629 DUODENAL ULCER 38 0.0054
630 PRODUCT ADMINISTRATION ERROR 108 0.0053
631 NERVE COMPRESSION 49 0.0053
632 NERVE INJURY 59 0.0053
633 APPETITE DISORDER 35 0.0053
634 CEREBROVASCULAR ACCIDENT 891 0.0053
635 COVID-19 PNEUMONIA 62 0.0052
636 BACTERAEMIA 62 0.0052
637 PROCEDURAL COMPLICATION 40 0.0052
638 THERAPY PARTIAL RESPONDER 81 0.0052
639 GOUT 93 0.0052
640 GASTROINTESTINAL PAIN 57 0.0052
641 CHEST DISCOMFORT 529 0.0052
642 TACHYCARDIA 459 0.0052
643 SPINAL OPERATION 63 0.0051
644 PRODUCT QUALITY ISSUE 694 0.0051
645 STRESS 368 0.0051
646 DEVICE LEAKAGE 221 0.0051
647 JOINT EFFUSION 35 0.0051
648 ANGINA UNSTABLE 33 0.0051
649 CARDIAC OPERATION 43 0.0050
650 OROPHARYNGEAL PAIN 457 0.0049
651 MOUTH ULCERATION 104 0.0049
652 CYTOMEGALOVIRUS INFECTION 82 0.0049
653 EPISTAXIS 368 0.0049
654 PRODUCT DISPENSING ERROR 107 0.0049
655 PRODUCT CONTAINER ISSUE 42 0.0049
656 CAESAREAN SECTION 57 0.0049
657 COMPLICATION ASSOCIATED WITH DEVICE 71 0.0049
658 BACTERIAL INFECTION 91 0.0049
659 GAMMA-GLUTAMYLTRANSFERASE INCREASED 108 0.0049
660 PAIN OF SKIN 130 0.0048
661 GALLBLADDER DISORDER 86 0.0048
662 CLOSTRIDIUM DIFFICILE COLITIS 51 0.0048
663 BREAST CANCER 444 0.0048
664 PANCREATITIS ACUTE 107 0.0048
665 SKIN FISSURES 93 0.0048
666 HYPERAESTHESIA 39 0.0047
667 ABNORMAL LOSS OF WEIGHT 32 0.0047
668 SPLENOMEGALY 55 0.0047
669 ABDOMINAL PAIN LOWER 116 0.0046
670 SLEEP APNOEA SYNDROME 86 0.0045
671 PNEUMONIA BACTERIAL 41 0.0045
672 LEUKAEMIA 42 0.0044
673 NODULE 58 0.0044
674 BLOOD ALBUMIN DECREASED 35 0.0044
675 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 230 0.0044
676 PHARYNGEAL SWELLING 43 0.0044
677 INTERVERTEBRAL DISC PROTRUSION 96 0.0044
678 UTERINE LEIOMYOMA 32 0.0044
679 BLOOD DISORDER 35 0.0044
680 THERAPEUTIC RESPONSE SHORTENED 144 0.0043
681 AORTIC ANEURYSM 33 0.0043
682 NEUTROPHIL COUNT INCREASED 44 0.0043
683 THROAT TIGHTNESS 116 0.0043
684 HYPOALBUMINAEMIA 33 0.0042
685 BODY TEMPERATURE INCREASED 86 0.0042
686 MYASTHENIA GRAVIS 34 0.0042
687 DIABETES MELLITUS 319 0.0042
688 TOOTH EXTRACTION 52 0.0042
689 ERYTHEMA 846 0.0041
690 FOOT FRACTURE 78 0.0041
691 FALL 1355 0.0041
692 LIMB INJURY 107 0.0039
693 SPINAL DISORDER 37 0.0039
694 THERAPY INTERRUPTED 278 0.0039
695 PNEUMOCYSTIS JIROVECII PNEUMONIA 39 0.0039
696 ACNE 293 0.0039
697 ACUTE CORONARY SYNDROME 32 0.0039
698 BACK PAIN 897 0.0039
699 HYPOKINESIA 55 0.0038
700 LEUKOPENIA 189 0.0038
701 HEPATOMEGALY 37 0.0038
702 PHOTOSENSITIVITY REACTION 62 0.0038
703 WRIST FRACTURE 45 0.0038
704 OPTIC NEURITIS 34 0.0037
705 PHOTOPHOBIA 70 0.0037
706 CONJUNCTIVITIS 69 0.0037
707 OVARIAN CANCER 34 0.0037
708 GASTRITIS 97 0.0037
709 HEPATOTOXICITY 82 0.0037
710 ILLNESS 373 0.0036
711 BLOOD CREATININE INCREASED 236 0.0036
712 INCORRECT PRODUCT ADMINISTRATION DURATION 78 0.0036
713 DEVICE OCCLUSION 50 0.0035
714 DEMENTIA 99 0.0035
715 LYMPHOPENIA 50 0.0035
716 PROSTATE CANCER 283 0.0035
717 SCAR 60 0.0035
718 ISCHAEMIC STROKE 62 0.0035
719 ASPIRATION 38 0.0035
720 INCORRECT DOSE ADMINISTERED 792 0.0035
721 BLOOD PRESSURE INCREASED 528 0.0034
722 BREAST CANCER STAGE I 32 0.0034
723 BLOOD TRIGLYCERIDES INCREASED 61 0.0034
724 ACCIDENT 41 0.0034
725 BLADDER DISORDER 34 0.0034
726 MYALGIA 581 0.0034
727 PROSTATIC SPECIFIC ANTIGEN INCREASED 47 0.0034
728 HALLUCINATION, AUDITORY 54 0.0034
729 SYNCOPE 339 0.0034
730 MUSCULOSKELETAL CHEST PAIN 52 0.0034
731 BODY TEMPERATURE DECREASED 33 0.0034
732 LIGAMENT SPRAIN 33 0.0033
733 NEURALGIA 81 0.0033
734 TENDON RUPTURE 41 0.0033
735 UNEVALUABLE EVENT 251 0.0033
736 COUGH 930 0.0033
737 MYOCARDIAL INFARCTION 577 0.0033
738 PALPITATIONS 387 0.0033
739 ECZEMA 172 0.0033
740 GASTRIC ULCER 62 0.0033
741 PREMATURE BABY 98 0.0033
742 PARANOIA 56 0.0032
743 DYSPHAGIA 308 0.0032
744 HYPERSOMNIA 93 0.0032
745 PERITONITIS 67 0.0032
746 INTERSTITIAL LUNG DISEASE 155 0.0032
747 BEDRIDDEN 42 0.0032
748 CARDIOMYOPATHY 47 0.0032
749 HYPERTHYROIDISM 46 0.0032
750 DENTAL CARIES 35 0.0032
751 PNEUMOTHORAX 50 0.0032
752 SWELLING FACE 205 0.0031
753 NASAL CONGESTION 185 0.0031
754 SUBARACHNOID HAEMORRHAGE 32 0.0031
755 SEPTIC SHOCK 136 0.0031
756 VERTIGO 190 0.0031
757 MULTIPLE SCLEROSIS 149 0.0031
758 DRUG EFFECT LESS THAN EXPECTED 46 0.0031
759 HAEMORRHAGE 323 0.0031
760 SCRATCH 32 0.0030
761 ACUTE MYOCARDIAL INFARCTION 89 0.0030
762 NERVOUS SYSTEM DISORDER 94 0.0030
763 POLYNEUROPATHY 36 0.0030
764 INJURY ASSOCIATED WITH DEVICE 61 0.0030
765 BURNING SENSATION 210 0.0030
766 RIB FRACTURE 61 0.0030
767 UPPER LIMB FRACTURE 59 0.0030
768 BLOOD URINE PRESENT 56 0.0029
769 DEEP VEIN THROMBOSIS 189 0.0029
770 ACUTE MYELOID LEUKAEMIA 45 0.0029
771 MYOCARDITIS 33 0.0029
772 SEIZURE 332 0.0029
773 PRODUCT USE COMPLAINT 45 0.0029
774 MENTAL DISORDER 124 0.0028
775 LOSS OF CONSCIOUSNESS 364 0.0028
776 DISEASE RECURRENCE 135 0.0028
777 PLATELET COUNT INCREASED 37 0.0028
778 PULMONARY EMBOLISM 269 0.0028
779 RASH ERYTHEMATOUS 135 0.0028
780 DERMATITIS ALLERGIC 35 0.0028
781 BLOOD TEST ABNORMAL 39 0.0028
782 IMPAIRED WORK ABILITY 59 0.0028
783 DEAFNESS 72 0.0028
784 THROMBOSIS 221 0.0027
785 HEPATIC CANCER 66 0.0027
786 HIATUS HERNIA 35 0.0027
787 PARAESTHESIA ORAL 39 0.0027
788 OSTEOPENIA 41 0.0027
789 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 546 0.0027
790 BRAIN OEDEMA 34 0.0027
791 ANAPHYLACTIC SHOCK 69 0.0027
792 FLATULENCE 151 0.0027
793 PULMONARY CONGESTION 35 0.0027
794 SKIN DISCOLOURATION 122 0.0027
795 TOOTH DISORDER 59 0.0027
796 HEAD INJURY 84 0.0027
797 ROTATOR CUFF SYNDROME 34 0.0026
798 SWOLLEN TONGUE 82 0.0026
799 DRUG RESISTANCE 67 0.0026
800 INJECTION SITE HAEMORRHAGE 208 0.0026
801 POOR QUALITY SLEEP 56 0.0026
802 PANCREATIC CARCINOMA 75 0.0026
803 SPINAL FRACTURE 52 0.0026
804 PRURITUS GENERALISED 56 0.0026
805 THERAPEUTIC RESPONSE UNEXPECTED 116 0.0026
806 CEREBRAL INFARCTION 63 0.0026
807 PRODUCT PHYSICAL ISSUE 52 0.0026
808 RENAL DISORDER 120 0.0026
809 MUSCULOSKELETAL DISCOMFORT 44 0.0026
810 SENSORY DISTURBANCE 41 0.0026
811 DEHYDRATION 337 0.0025
812 INTRAOCULAR PRESSURE INCREASED 32 0.0025
813 DEVICE USE ERROR 87 0.0025
814 LETHARGY 144 0.0025
815 EYE SWELLING 93 0.0025
816 ANAEMIA 475 0.0025
817 RASH MACULAR 87 0.0025
818 HIP FRACTURE 80 0.0025
819 INCORRECT DOSE ADMINISTERED BY DEVICE 65 0.0025
820 INJECTION SITE RASH 76 0.0025
821 INCORRECT ROUTE OF DRUG ADMINISTRATION 88 0.0025
822 FLUSHING 250 0.0025
823 EOSINOPHILIA 43 0.0025
824 RENAL IMPAIRMENT 206 0.0024
825 COLD SWEAT 43 0.0024
826 PRODUCTIVE COUGH 116 0.0024
827 THROAT IRRITATION 109 0.0024
828 LIMB DISCOMFORT 75 0.0024
829 MYELODYSPLASTIC SYNDROME 35 0.0024
830 ASCITES 71 0.0024
831 VISION BLURRED 330 0.0024
832 DEPRESSED MOOD 127 0.0024
833 RASH GENERALISED 62 0.0024
834 ACUTE RESPIRATORY FAILURE 46 0.0024
835 PNEUMONITIS 65 0.0024
836 DRY SKIN 318 0.0024
837 INJECTION SITE SWELLING 182 0.0024
838 ACUTE RESPIRATORY DISTRESS SYNDROME 42 0.0024
839 DIABETES MELLITUS INADEQUATE CONTROL 42 0.0024
840 ATRIAL FIBRILLATION 231 0.0024
841 PSYCHOTIC DISORDER 70 0.0024
842 THROMBOCYTOPENIA 256 0.0023
843 HAEMATURIA 78 0.0023
844 PANIC ATTACK 83 0.0023
845 PRESYNCOPE 55 0.0023
846 GASTRIC CANCER 57 0.0022
847 MUCOSAL INFLAMMATION 58 0.0022
848 HYPERHIDROSIS 285 0.0022
849 BLINDNESS 90 0.0022
850 PROCEDURAL PAIN 61 0.0022
851 MIDDLE INSOMNIA 41 0.0022
852 BLOOD POTASSIUM DECREASED 66 0.0022
853 CARDIAC FAILURE 176 0.0022
854 HOT FLUSH 163 0.0022
855 EYE DISORDER 71 0.0022
856 DYSSTASIA 63 0.0022
857 ANGIOEDEMA 95 0.0021
858 TUBULOINTERSTITIAL NEPHRITIS 40 0.0021
859 FAECES DISCOLOURED 46 0.0021
860 MOVEMENT DISORDER 68 0.0021
861 TOOTHACHE 38 0.0021
862 RASH PAPULAR 47 0.0021
863 CHILLS 244 0.0021
864 FRACTURE 39 0.0021
865 HAEMOGLOBIN DECREASED 210 0.0020
866 LEUKOCYTOSIS 37 0.0020
867 HYPOTHYROIDISM 65 0.0020
868 HEAD DISCOMFORT 36 0.0020
869 BONE DISORDER 37 0.0020
870 CONSTIPATION 441 0.0020
871 DYSPHONIA 118 0.0020
872 CARDIOVASCULAR DISORDER 51 0.0020
873 FEELING ABNORMAL 477 0.0020
874 HEART RATE INCREASED 196 0.0020
875 INJECTION SITE PAIN 606 0.0020
876 THIRST 35 0.0020
877 NEUROPATHY PERIPHERAL 186 0.0020
878 PLASMA CELL MYELOMA 76 0.0019
879 INTENTIONAL PRODUCT MISUSE 169 0.0019
880 DRUG PRESCRIBING ERROR 37 0.0019
881 INJECTION SITE BRUISING 153 0.0019
882 BLOOD PRESSURE FLUCTUATION 46 0.0019
883 MUSCLE TWITCHING 44 0.0019
884 BLOOD ALKALINE PHOSPHATASE INCREASED 47 0.0019
885 ERECTILE DYSFUNCTION 48 0.0019
886 BLOOD PRESSURE ABNORMAL 37 0.0019
887 OSTEONECROSIS 61 0.0019
888 DIPLOPIA 48 0.0018
889 DEVICE USE ISSUE 32 0.0018
890 HEPATIC FAILURE 55 0.0018
891 HEART RATE IRREGULAR 41 0.0018
892 EXPOSURE VIA SKIN CONTACT 47 0.0018
893 PALLOR 49 0.0018
894 INJECTION SITE ERYTHEMA 223 0.0018
895 DRY EYE 89 0.0018
896 HYPOKALAEMIA 82 0.0018
897 CEREBRAL HAEMORRHAGE 63 0.0018
898 PRODUCT PRESCRIBING ISSUE 38 0.0017
899 DRUG DOSE OMISSION BY DEVICE 136 0.0017
900 RENAL CANCER 82 0.0017
901 LACRIMATION INCREASED 52 0.0017
902 EXPIRED PRODUCT ADMINISTERED 57 0.0017
903 PRODUCT AVAILABILITY ISSUE 39 0.0017
904 SUICIDAL IDEATION 156 0.0017
905 BLOOD CREATINE PHOSPHOKINASE INCREASED 49 0.0017
906 BLADDER CANCER 100 0.0017
907 CARDIAC DISORDER 158 0.0017
908 PERICARDIAL EFFUSION 39 0.0017
909 SKIN BURNING SENSATION 120 0.0017
910 PLEURAL EFFUSION 101 0.0017
911 BONE PAIN 96 0.0016
912 MELAENA 36 0.0016
913 INJECTION SITE PRURITUS 109 0.0016
914 ARRHYTHMIA 77 0.0016
915 MULTIPLE ORGAN DYSFUNCTION SYNDROME 46 0.0016
916 LIP SWELLING 54 0.0016
917 HAEMATOMA 42 0.0016
918 CARDIAC FAILURE CONGESTIVE 130 0.0016
919 SKIN IRRITATION 71 0.0015
920 MOOD SWINGS 49 0.0015
921 HYPOACUSIS 65 0.0015
922 GLYCOSYLATED HAEMOGLOBIN INCREASED 38 0.0015
923 DYSURIA 55 0.0015
924 EYE PAIN 84 0.0015
925 JAUNDICE 40 0.0015
926 RESPIRATORY DISTRESS 41 0.0015
927 DEATH 1272 0.0015
928 OVERDOSE 318 0.0015
929 NERVOUSNESS 77 0.0015
930 INJECTION SITE MASS 54 0.0015
931 GASTROINTESTINAL HAEMORRHAGE 121 0.0014
932 MENTAL IMPAIRMENT 35 0.0014
933 PNEUMONIA ASPIRATION 36 0.0014
934 RESPIRATORY FAILURE 105 0.0014
935 TINNITUS 66 0.0014
936 RED BLOOD CELL COUNT DECREASED 41 0.0014
937 POLLAKIURIA 59 0.0014
938 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 41 0.0014
939 SPEECH DISORDER 73 0.0014
940 RENAL FAILURE 185 0.0014
941 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 64 0.0014
942 FEELING COLD 37 0.0013
943 FEMUR FRACTURE 41 0.0013
944 PULMONARY OEDEMA 59 0.0013
945 HEART RATE DECREASED 46 0.0013
946 HYPOTENSION 262 0.0013
947 ENCEPHALOPATHY 32 0.0013
948 BLOOD BILIRUBIN INCREASED 35 0.0013
949 TREMOR 213 0.0013
950 EYE PRURITUS 43 0.0013
951 OCULAR HYPERAEMIA 60 0.0013
952 URINARY RETENTION 42 0.0013
953 CORONARY ARTERY DISEASE 38 0.0013
954 WHITE BLOOD CELL COUNT DECREASED 136 0.0013
955 HYPOPHAGIA 32 0.0013
956 DISORIENTATION 49 0.0012
957 BLOOD PRESSURE DECREASED 82 0.0012
958 DYSPNOEA EXERTIONAL 45 0.0012
959 ACUTE KIDNEY INJURY 182 0.0012
960 BALANCE DISORDER 102 0.0012
961 EMOTIONAL DISTRESS 129 0.0011
962 DISEASE PROGRESSION 125 0.0011
963 PRODUCT SUBSTITUTION ISSUE 57 0.0010
964 COMA 47 0.0010
965 SOMNOLENCE 198 0.0010
966 DYSGEUSIA 72 0.0010
967 CHRONIC KIDNEY DISEASE 73 0.0010
968 BLOOD GLUCOSE INCREASED 180 0.0010
969 DEVICE BREAKAGE 37 0.0009
970 CARDIAC ARREST 75 0.0009
971 DISTURBANCE IN ATTENTION 48 0.0009
972 CARDIO-RESPIRATORY ARREST 36 0.0009
973 PLATELET COUNT DECREASED 89 0.0008
974 DERMATITIS ATOPIC 43 0.0008
975 HYPOGLYCAEMIA 38 0.0008
976 SUICIDE ATTEMPT 47 0.0008
977 EYE IRRITATION 44 0.0008
978 WITHDRAWAL SYNDROME 32 0.0008
979 PANCYTOPENIA 42 0.0008
980 OXYGEN SATURATION DECREASED 41 0.0007
981 COGNITIVE DISORDER 33 0.0007
982 BLOOD GLUCOSE DECREASED 33 0.0007
983 DRUG INTERACTION 106 0.0007
984 NEUTROPENIA 87 0.0006
985 IRRITABILITY 38 0.0006
986 HALLUCINATION 46 0.0006
987 NO ADVERSE EVENT 97 0.0005
988 AGITATION 39 0.0005
989 DEVICE DIFFICULT TO USE 33 0.0005
990 TOXICITY TO VARIOUS AGENTS 46 0.0003